The Cost Effectiveness of Orlistat in a 1-Year Weight-Management Programme for Treating Overweight and Obese Patients in Sweden: A Treatment Responder Approach

Author： Hertzman Peter  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.10, 2005-01, pp. : 1007-1020

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus

By Maetzel A.  

PharmacoEconomics, Vol. 21, Iss. 7, 2003-01 ,pp. : 501-512

Adis International

Access to resources Recommend Favorite

A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patients with Severe Chronic Obstructive Pulmonary Disease

By Mölken Maureen P.M.H. Rutten-van  

PharmacoEconomics, Vol. 25, Iss. 8, 2007-01 ,pp. : 695-711

Adis International

Access to resources Recommend Favorite

Comparison of orlistat treatment and placebo in obese type 2 diabetic patients

By Derosa Giuseppe   Maffioli Pamela   Salvadeo Sibilla AT   Ferrari Ilaria   Gravina Alessia   Mereu Roberto   D'Angelo Angela   Fogari Elena   Palumbo Ilaria   Randazzo Sabrina   Cicero Arrigo FG  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. : 1971-1982

Informa Healthcare

Access to resources Recommend Favorite

Orlistat - a new approach to weight management in type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1267, 2000-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of an Adherence-Improving Programme in Hypertensive Patients

By Brunenberg Danielle E.M.  

PharmacoEconomics, Vol. 25, Iss. 3, 2007-01 ,pp. : 239-251

Adis International

Access to resources Recommend Favorite